Beta Bionics, Inc. Defined Contribution Plan, Cost
Beta Bionics, Inc. (BBNX) reported Defined Contribution Plan, Cost of $1.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-07-29
- Beta Bionics, Inc. defined contribution plan, cost for the quarter ending 2026-06-30 was $1.00M, a 42.86% increase year-over-year.
- Beta Bionics, Inc. defined contribution plan, cost for the quarter ending 2026-03-31 was $900.00K, a 28.57% increase year-over-year.
- Beta Bionics, Inc. defined contribution plan, cost for the quarter ending 2025-12-31 was $800.00K, a 33.33% increase year-over-year.
- Beta Bionics, Inc. defined contribution plan, cost for the quarter ending 2025-09-30 was $800.00K, a 33.33% increase year-over-year.
- Beta Bionics, Inc. defined contribution plan, cost for fiscal 2025 was $3.00M, a 36.36% increase from fiscal 2024.
- Beta Bionics, Inc. defined contribution plan, cost for fiscal 2024 was $2.20M, a 83.33% increase from fiscal 2023.
- Beta Bionics, Inc. defined contribution plan, cost for fiscal 2023 was $1.20M.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.90M 10-Q · filed 2026-07-29 | $2.70M derived: sum of 3 quarters · filed 2026-07-29 | $3.50M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $900.00K 10-Q · filed 2026-04-21 | $1.70M derived: sum of 2 quarters · filed 2026-04-21 | $2.50M derived: sum of 3 quarters · filed 2026-04-21 | $3.20M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.60M derived: sum of 2 quarters · filed 2026-02-24 | $2.30M derived: sum of 3 quarters · filed 2026-07-29 | $3.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.50M derived: sum of 2 quarters · filed 2026-07-29 | $2.20M 10-Q · filed 2025-10-28 | $2.80M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.40M 10-Q · filed 2026-07-29 | $2.00M derived: sum of 3 quarters · filed 2026-07-29 | $2.60M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $700.00K 10-Q · filed 2026-04-21 | $1.30M derived: sum of 2 quarters · filed 2026-04-21 | $1.90M derived: sum of 3 quarters · filed 2026-04-21 | $2.40M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.20M derived: sum of 2 quarters · filed 2026-02-24 | $1.70M derived: sum of 3 quarters · filed 2026-02-24 | $2.20M 10-K · filed 2026-02-24 |
| 2024-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.10M derived: sum of 2 quarters · filed 2025-10-28 | $1.60M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.00M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $500.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $1.20M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |